Barclays raised the firm’s price target on CSX (CSX) to $38 from $36 and keeps an Overweight rating on the shares post the Q2 report. The company posted solid cost recovery and management’s optimism on volumes is positive for the fundamental outlook, the analyst tells investors in a research note. The firm believes takeover speculation will likely to dominate investor focus for the time being, however.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CSX:
